SCHEMBL5014949

SCHEMBL5014949

NC(=O)c1cccc2cc(-c3ccccc3O)ccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
ALDH1A1 P00352 2/20 0.55
GAA P10253 1/20 0.55
HSD17B1 P14061 7/20 0.49
HSD17B2 P37059 7/20 0.49
ESR2 Q92731 3/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MCL1 Q07820 1/20 0.47
ACMSD Q8TDX5 1/20 0.47
ESR1 P03372 2/20 0.44
BCAT2 O15382 1/20 0.44
TLR8 Q9NR97 1/20 0.43
PARP1 P09874 2/20 0.43
KDR P35968 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5553183 0.85 KDM4E (0.46) KDM4EALDH1A1GAAHSD17B1HSD17B2
SCHEMBL634882 0.84 KDM4E (0.65) KDM4EALDH1A1GAAHSD17B1HSD17B2
SCHEMBL5023244 0.81 PARP1 (0.50) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL5016686 0.79 KDM4E (0.48) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL2381295 0.77 KDM4E (0.46) KDM4EALDH1A1GAAPARP1KDR
SCHEMBL27582824 0.76 ESR2 (0.62) ALDH1A1HSD17B1HSD17B2ESR2HPGD
SCHEMBL1807859 0.76 KDM4E (0.62) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL634716 0.75 KDM4E (0.53) KDM4EALDH1A1GAAHSD17B1HSD17B2
SCHEMBL31621279 0.74 SLC6A2 (0.64) KDM4EALDH1A1GAAESR2HPGD
SCHEMBL21071005 0.74 HSD17B1 (0.76) ALDH1A1HSD17B1HSD17B2ESR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449608-B2 Naphthol derivative and charge control agent comprising the same UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2008-11-11 US disclosed
US-20050119487-A1 Naphthol derivative and charge control agent comprising the same KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2005-06-02 US disclosed
EP-1462440-A1 NAPHTHOL DERIVATIVE AND CHARGE CONTROL AGENT COMPRISING THE SAME Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 2004-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119487-A1 Naphthol derivative and charge control agent comprising the same CECR2, PEF1, NAP1L1 KDM4E 2651/4885ALDH1A1 3851/4885GAA 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.